Expression of NGF in Estradiol Valerate-Induced Polycystic Ovary and CHO Cells |
Choi, Baik-Dong
(Department of Oral Histology and Developmental Biology, School of Dentistry, Chosun University)
Jeong, Soon-Jeong (Department of Oral Histology and Developmental Biology, School of Dentistry, Chosun University) Jeong, Moon-Jin (Department of Oral Histology and Developmental Biology, School of Dentistry, Chosun University) Lim, Do-Seon (Department of Dental Hygiene, Eulji University) Lee, Soo-Han (College of Veterinary Medicine, Konkuk University) Kim, Seung-Hyun (College of Veterinary Medicine, Chonnam National University) Go, A-Ra (College of Veterinary Medicine, Chonnam National University) Kim, Se-Eun (College of Veterinary Medicine, Chonnam National University) Kang, Seong-Soo (College of Veterinary Medicine, Chonnam National University) Bae, Chun-Sik (College of Veterinary Medicine, Chonnam National University) |
1 | Balen AH: The pathogenesis of polycystic ovary syndrome: the enigma unravels. Lancet 354 : 966-967, 1999. DOI ScienceOn |
2 | Barria A, Leyton V, Ojeda SR, Lara HE: Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 133 : 2696-2703, 1993. DOI ScienceOn |
3 | Conner P, Register TC, Skoog L, Tani E, von Schoultz B, Cline JM: Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys. Am J Obstet Gynecol 193(1) : 58-63, 2005. DOI ScienceOn |
4 | Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, Bellastella A, Carella C, Izzo A: Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 101 : 1177-1182, 2003. DOI ScienceOn |
5 | Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82 : 2248-2256, 1997. DOI ScienceOn |
6 | Artini PG, Monteleone P, Toldin MRP, Matteucci C, Ruggiero M, Cela V, Genazzani AR: Growth factors and folliculogenesis in polycystic ovary patients. Expert Rev Endocrinol Metab 2 : 215-223, 2007. DOI |
7 | Zhuang YH, Sarca D, Weisz A, Altucci L, Cicatiello L, Rollerova E, Tuohimaa P, Ylikomi T: Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27(kip1) expression by estrogen in rat endometrium. J Steroid Biochem Mol Biol 78(2) : 193-199, 2001. DOI ScienceOn |
8 | Stener-Victorin E, Lundeberg T, Cajander S, Aloe L, Manni L, Waldenstrom U, Janson PO: Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin- 1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. Reprod Biol Endocrinol 1 : 33-40, 2003. DOI |
9 | Taishi P, Churchill L, De A, Obal F Jr, Krueger JM: Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo. Brain Res 1226 : 89-98, 2008. |
10 | Takaoka K, Shirai Y, Saito N: Inflammatory cytokine tumor necrosis factor-alpha enhances nerve growth factor production in human keratinocytes, HaCaT cells. J Pharmacol Sci 111(4) : 381-391, 2009. DOI ScienceOn |
11 | Tokusashi Y, Asai K, Tamakawa S, Yamamoto M, Yoshie M, Yaginuma Y, Miyokawa N, Aoki T, Kino S, Kasai S, Ogawa K: Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. Int J Cancer 114 : 39-45, 2005. DOI ScienceOn |
12 | Tokushige N, Markham R, Russell P, Fraser IS: High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod 21 : 782-787, 2006. |
13 | Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147(1) : 71-79, 2002. DOI ScienceOn |
14 | Vaitukaitis JL: Polycystic-ovary syndrome-what is it? N Engl J Med 309 : 1245-1246, 1983. DOI ScienceOn |
15 | Lara HE, McDonald JK, Ojeda SR: Involvement of nerve growth factor in female sexual development. Endocrinology 126 : 364-375, 1990. DOI ScienceOn |
16 | Li HJ, Wang LY, Qu HN, Yu LH, Burnstock G, Ni X, Xu M, Ma B: P2Y(2) receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Mol Cell Endocrinol 338(1-2) : 28-37, 2011. |
17 | Pak SC, Kim SE, Oh DM, Shim KM, Jeong MJ, Lim SC, Nah SY, Park SH, Kang SS, Moon CJ, Kim JC, Kim SH, Bae CS: Effect of Korean red ginseng extract in a steroid-induced polycystic ovary murine model. Arch Pharm Res 32(3) : 347-352, 2009. DOI |
18 | Shirwalkar H, Modi DN, Maitra A: Exposure of adult rats to estradiol valerate induces ovarian cyst with early senescence of follicles. Mol Cell Endocrinol 272(1-2) : 22-37, 2007. DOI ScienceOn |
19 | Proto MC, Gazzerro P, Di Croce L, Santoro A, Malfitano AM, Pisanti S, Laezza C, Bifulco M: Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. J Cell Physiol doi: 10.1002/jcp.22727, 2011. |
20 | Seidel MF, Herguijuela M, Forkert R, Otten U: Nerve growth factor in rheumatic diseases. Semin Arthritis Rheum 40(2) : 109-126, 2010. DOI ScienceOn |
21 | Snider WD: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77(5) : 627-638, 1994. DOI ScienceOn |
22 | Sofroniew MV, Howe CL, Mobley WC: Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24 : 1217-1281, 2001. DOI ScienceOn |
23 | Do Y, Ryu S, Nagarkatti M, Nagarkatti PS: Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. Toxicol Sci 70(1) : 63-72, 2002. DOI |
24 | Lara HE, Dissen GA, Leyton V, Paredes A, Fuenzalida H, Fiedler JL, Ojeda SR: An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology 141 : 1059-1072, 2000. DOI ScienceOn |
25 | Doren M: Basic principles of hormone replacement therapy in the postmenopause. Ther Umsch 57(10) : 628-634, 2000. DOI ScienceOn |
26 | Ferin M, Jewelewicz R, Warren M: Menstruacni cyklus. Grada Publishing, Praha, pp. 80-83, 1997. |
27 | Franks S: Polycystic ovary syndrome. N Engl J Med 333 : 853-861, 1995. DOI ScienceOn |
28 | Lara HE, Ferruz JL, Luza S, Bustamante DA, Borges Y, Ojeda SR: Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 133(6) : 2690-2695, 1993. DOI ScienceOn |
29 | Creasy GW, Kafrissen ME, Upmalis D: Review of the endometrial effects of estrogens and progestins. Obstet Gynecol Surv 47(9) : 654-678, 1992. DOI ScienceOn |
30 | Dissen GA, Garcia-Rudaz C, Paredes A, Mayer C, Mayerhofer A, Ojeda SR: Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans. Endocrinology 150(6) : 2906-2914, 2009. DOI ScienceOn |
31 | Dissen GA, Hill DF, Costa ME, Dees WL, Lara HE, Ojeda SR: A role for trkA nerve growth factor receptors in mammalian ovulation. Endocrinology 137 : 198-209, 1996. DOI ScienceOn |
32 | Dissen GA, Lara HE, Leyton V, Paredes A, Hill DF, Costa ME, Martinez-Serrano A, Ojeda SR: Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology 141(3) : 1073-1082, 2000. DOI ScienceOn |